Efficacy of IVMED-85 on Pediatric Myopia

计划入组 216 人 · 首次发布于 2023 年 3 月 9 日

Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.

计划入组 123 人 · 首次发布于 2024 年 4 月 29 日

Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression

计划入组 80 人 · 首次发布于 2022 年 4 月 15 日

Progressive MS(CuroNZ)

Pediatric SHLQ

progressive supranuclear palsy program

CENTER FOR PROGRESSIVE RECOVERY

United States

CENTER FOR PROGRESSIVE RECOVERY, LLC

United States

Landon Pediatric Foundation

United States

FDA Rejection of Low-Dose Atropine Sparks Industry Petition and Calls for Myopia Reclassification

FDA to Convene Advisory Committee to Review Sydnexis's SYD-101 for Pediatric Progressive Myopia

FDA Accepts NDA for Sydnexis' SYD-101: First Potential Pharmaceutical Treatment for Pediatric Myopia